Position in JNJ
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$7,825,069
-$5,996,056 QoQ
Shares Held
30,811
-45.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,261
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 10%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST CITIZENS BANK & TRUST CO holds $87,047,230 across 11 Drug Manufacturers - General names. JNJ ranks #5 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
31,493 | $37,773,651 | |
| 2 | ABBV |
AbbVie Inc.
|
43,514 | $10,949,862 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
73,799 | $9,323,765 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,055 | $8,231,067 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
30,811 | $7,825,069 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
94,434 | $5,441,286 | |
| 7 | AMGN |
Amgen Inc
|
9,717 | $3,518,719 | |
| 8 | PFE |
Pfizer Inc
|
79,991 | $1,926,182 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,825,069 | 30,811 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $13,821,125 | 56,542 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $11,537,875 | 55,752 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $10,629,757 | 57,328 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $9,269,175 | 60,682 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $11,962,370 | 72,132 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $10,230,996 | 70,744 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $11,978,340 | 73,913 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $8,509,434 | 58,220 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $9,271,515 | 58,610 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $6,126,652 | 39,088 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $6,975,263 | 44,785 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $8,418,181 | 50,859 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $7,361,570 | 47,494 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,742,023 | 38,166 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $6,866,020 | 42,030 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $6,156,578 | 34,683 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $5,986,651 | 33,779 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $11,332,702 | 66,246 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $10,869,918 | 67,306 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $11,476,117 | 69,662 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $11,510,580 | 70,037 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $11,049,491 | 70,209 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $10,952,058 | 73,563 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $12,530,695 | 89,104 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $9,659,297 | 73,662 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||